CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

PureTech to Present LYT-200 Phase 1b Results in MDS, AML at ESMO 2026

By Public Technologies
  • PureTech Health will present Phase 1b LYT-200 results at ESMO in Madrid on October 24, 2026.
  • Results showed encouraging clinical activity with favorable safety in heavily pretreated patients with relapsed/refractory high-risk myelodysplastic syndromes and acute myeloid leukemia.
  • Gallop Oncology plans to advance LYT-200 into the Phase 2 STRIDE-MDS trial for relapsed/refractory high-risk myelodysplastic syndromes following FDA discussions.
  • The drug received FDA Fast Track designation, supporting development in a population with limited treatment options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PureTech Health plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202610190200BIZWIRE_USPR_____20261018_BW068368) on October 19, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk